Compounded GLP-1 medications through telehealth platforms: These platforms facilitate access to compounded semaglutide or tirzepatide prepared by licensed compounding pharmacies
The study found no increase in pancreatic cancer risk with GLP-1RA use, and several sensitivity analyses suggested a modest, non-significant reduction in incidence (Wang et al., 2025)
It is important to individualise the approach when switching from one GLP1RA to another, and the patient should be consulted before the switch is initiated
The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils
The 2-hour post-meal window ensures a fasted state at the time of injection
If bleeding occurs, apply gentle pressure with a clean gauze pad